MRSN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Mersana Therapeutics Inc (MRSN).


$176.65M Market Cap.

As of 03/03/2025 5:00 PM ET (MRY) • Disclaimer

MRSN Market Cap. (MRY)


MRSN Shares Outstanding (MRY)


MRSN Assets (MRY)


Total Assets

$144.66M

Total Liabilities

$154.17M

Total Investments

$26.87M

MRSN Income (MRY)


Revenue

$40.50M

Net Income

-$69.19M

Operating Expense

$113.83M

MRSN Cash Flow (MRY)


CF Operations

-$82.34M

CF Investing

$11.44M

CF Financing

$4.09M

MRSN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MRSN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$144,663,000 (-36.01%)

$226,060,000 (-32.39%)

$334,340,000 (62.21%)

$206,111,000 (-24.61%)

Assets Current

$136,904,000 (-36.04%)

$214,057,000 (-32.94%)

$319,219,000 (68.99%)

$188,898,000 (-26.95%)

Assets Non-Current

$7,759,000 (-35.36%)

$12,003,000 (-20.62%)

$15,121,000 (-12.15%)

$17,213,000 (16.15%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$9,509,000 (-125.77%)

$36,904,000 (-59.91%)

$92,057,000 (-24.38%)

$121,741,000 (-46.63%)

Property Plant & Equipment Net

$6,781,000 (-41.16%)

$11,525,000 (-20.30%)

$14,460,000 (-2.67%)

$14,857,000 (17.30%)

Cash & Equivalents

$107,750,000 (-38.27%)

$174,561,000 (35.44%)

$128,885,000 (-27.57%)

$177,947,000 (-30.24%)

Accumulated Other Comprehensive Income

$10,000 (-9.09%)

$11,000 (107.24%)

-$152,000 (0%)

$0 (0%)

Deferred Revenue

$101,632,000 (-18.90%)

$125,314,000 (-15.13%)

$147,653,000 (3643.74%)

$3,944,000 (-1.08%)

Total Investments

$26,870,000 (-22.17%)

$34,523,000 (-77.26%)

$151,827,000 (0%)

$0 (0%)

Investments Current

$26,870,000 (-22.17%)

$34,523,000 (-77.26%)

$151,827,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$30,000,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,330,000 (-40.84%)

$7,319,000 (-47.54%)

$13,951,000 (13.23%)

$12,321,000 (47.73%)

Accumulated Retained Earnings (Deficit)

-$895,553,000 (-8.37%)

-$826,361,000 (-26.22%)

-$654,691,000 (-45.33%)

-$450,479,000 (-60.64%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$28,598,000 (-14.97%)

$33,632,000 (-7.35%)

$36,302,000 (-4.91%)

$38,176,000 (130.36%)

Debt Current

$16,356,000 (206.58%)

$5,335,000 (90.67%)

$2,798,000 (21.49%)

$2,303,000 (60.26%)

Debt Non-Current

$12,242,000 (-56.74%)

$28,297,000 (-15.54%)

$33,504,000 (-6.60%)

$35,873,000 (137.02%)

Total Liabilities

$154,172,000 (-18.49%)

$189,156,000 (-21.93%)

$242,283,000 (187.17%)

$84,370,000 (86.20%)

Liabilities Current

$62,458,000 (-1.85%)

$63,637,000 (-30.48%)

$91,533,000 (92.61%)

$47,523,000 (58.39%)

Liabilities Non-Current

$91,714,000 (-26.93%)

$125,519,000 (-16.74%)

$150,750,000 (309.12%)

$36,847,000 (140.69%)

MRSN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$40,497,000 (9.88%)

$36,855,000 (38.65%)

$26,581,000 (61716.28%)

$43,000 (-94.81%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$40,813,000 (-31.46%)

$59,543,000 (4.53%)

$56,963,000 (54.42%)

$36,888,000 (68.42%)

Research & Development Expense

$73,020,000 (-50.75%)

$148,269,000 (-14.49%)

$173,385,000 (31.34%)

$132,013,000 (96.93%)

Operating Expenses

$113,833,000 (-47.43%)

$216,525,000 (-6.00%)

$230,348,000 (36.38%)

$168,901,000 (89.91%)

Interest Expense

$3,874,000 (-4.89%)

$4,073,000 (22.39%)

$3,328,000 (162.67%)

$1,267,000 (252.92%)

Income Tax Expense

$418,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$69,192,000 (59.69%)

-$171,670,000 (15.94%)

-$204,212,000 (-20.08%)

-$170,060,000 (-93.15%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$69,192,000 (59.69%)

-$171,670,000 (15.94%)

-$204,212,000 (-20.08%)

-$170,060,000 (-93.15%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$69,192,000 (59.69%)

-$171,670,000 (15.94%)

-$204,212,000 (-20.08%)

-$170,060,000 (-93.15%)

Weighted Average Shares

$122,539,598 (5.53%)

$116,112,891 (23.98%)

$93,654,243 (32.69%)

$70,580,949 (14.79%)

Weighted Average Shares Diluted

$122,539,598 (5.53%)

$116,112,891 (23.98%)

$93,654,243 (32.69%)

$70,580,949 (14.79%)

Earning Before Interest & Taxes (EBIT)

-$64,900,000 (61.28%)

-$167,597,000 (16.57%)

-$200,884,000 (-19.01%)

-$168,793,000 (-92.50%)

Gross Profit

$40,497,000 (9.88%)

$36,855,000 (38.65%)

$26,581,000 (61716.28%)

$43,000 (-94.81%)

Operating Income

-$73,336,000 (59.18%)

-$179,670,000 (11.83%)

-$203,767,000 (-20.67%)

-$168,858,000 (-91.64%)

MRSN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$11,437,000 (-90.46%)

$119,883,000 (178.50%)

-$152,716,000 (-23467.28%)

-$648,000 (-101.75%)

Net Cash Flow from Financing

$4,092,000 (-95.68%)

$94,675,000 (-38.13%)

$153,017,000 (140.42%)

$63,646,000 (-72.38%)

Net Cash Flow from Operations

-$82,340,000 (51.24%)

-$168,882,000 (-242.12%)

-$49,363,000 (64.74%)

-$139,988,000 (-87.41%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$66,811,000 (-246.27%)

$45,676,000 (193.10%)

-$49,062,000 (36.27%)

-$76,990,000 (-139.94%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$11,569,000 (-90.52%)

$122,051,000 (181.09%)

-$150,519,000 (0%)

$0 (0%)

Capital Expenditure

-$132,000 (93.91%)

-$2,168,000 (1.32%)

-$2,197,000 (-239.04%)

-$648,000 (-37.00%)

Issuance (Repayment) of Debt Securities

-$2,230,000 (-441.26%)

-$412,000 (-51.47%)

-$272,000 (-101.48%)

$18,341,000 (5959.74%)

Issuance (Purchase) of Equity Shares

$6,322,000 (-93.35%)

$95,087,000 (-37.97%)

$153,289,000 (236.43%)

$45,564,000 (-80.25%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$16,458,000 (-22.13%)

$21,136,000 (-1.79%)

$21,522,000 (16.91%)

$18,409,000 (156.68%)

Depreciation Amortization & Accretion

$4,744,000 (10.40%)

$4,297,000 (363.54%)

$927,000 (8.42%)

$855,000 (-15.35%)

MRSN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-170.90% (63.31%)

-465.80% (39.37%)

-768.30% (99.81%)

-395488.40% (-3619.27%)

EBITDA Margin

-148.50% (66.49%)

-443.10% (41.10%)

-752.30% (99.81%)

-390553.50% (-3630.89%)

Return on Average Equity (ROAE)

-990.20% (-250.64%)

-282.40% (-57.94%)

-178.80% (-76.33%)

-101.40% (-135.27%)

Return on Average Assets (ROAA)

-40.00% (36.10%)

-62.60% (11.08%)

-70.40% (4.22%)

-73.50% (-102.48%)

Return on Sales (ROS)

-160.30% (64.75%)

-454.70% (39.83%)

-755.70% (99.81%)

-392541.90% (-3606.69%)

Return on Invested Capital (ROIC)

-103.80% (48.51%)

-201.60% (19.36%)

-250.00% (90.25%)

-2562.80% (-425.38%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.55 (-62.88%)

-1.57 (41.67%)

-2.69 (-4.15%)

-2.58 (86.13%)

Price to Sales Ratio (P/S)

4.33 (-40.80%)

7.31 (-64.60%)

20.65 (-99.80%)

10,209.61 (416.68%)

Price to Book Ratio (P/B)

-18.58 (-345.08%)

7.58 (19.35%)

6.35 (72.86%)

3.67 (-54.02%)

Debt to Equity Ratio (D/E)

-16.21 (-416.29%)

5.13 (94.76%)

2.63 (279.80%)

0.69 (248.24%)

Earnings Per Share (EPS)

-0.56 (62.16%)

-1.48 (32.11%)

-2.18 (9.54%)

-2.41 (-68.53%)

Sales Per Share (SPS)

0.33 (4.10%)

0.32 (11.62%)

0.28 (28300.00%)

0 (-92.31%)

Free Cash Flow Per Share (FCFPS)

-0.67 (54.31%)

-1.47 (-167.33%)

-0.55 (72.35%)

-1.99 (-62.96%)

Book Value Per Share (BVPS)

-0.08 (-124.53%)

0.32 (-67.65%)

0.98 (-43.01%)

1.73 (-53.50%)

Tangible Assets Book Value Per Share (TABVPS)

1.18 (-39.34%)

1.95 (-45.46%)

3.57 (22.26%)

2.92 (-34.34%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1 (50.00%)

-2 (0.00%)

-2 (88.89%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.15 (-174.46%)

-0.78 (64.21%)

-2.19 (-33.74%)

-1.64 (90.96%)

Asset Turnover

0.23 (74.63%)

0.13 (45.65%)

0.09 (0%)

0 (0%)

Current Ratio

2.19 (-34.84%)

3.36 (-3.53%)

3.49 (-12.28%)

3.98 (-53.88%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$82,472,000 (51.78%)

-$171,050,000 (-231.75%)

-$51,560,000 (63.34%)

-$140,636,000 (-87.09%)

Enterprise Value (EV)

$129,289,060 (1.16%)

$127,809,504 (-70.78%)

$437,433,802 (59.18%)

$274,802,601 (-82.48%)

Earnings Before Tax (EBT)

-$68,774,000 (59.94%)

-$171,670,000 (15.94%)

-$204,212,000 (-20.08%)

-$170,060,000 (-93.15%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$60,156,000 (63.16%)

-$163,300,000 (18.33%)

-$199,957,000 (-19.07%)

-$167,938,000 (-93.75%)

Invested Capital

$3,053,000 (-85.80%)

$21,494,000 (-85.69%)

$150,224,000 (698.34%)

$18,817,000 (286.07%)

Working Capital

$74,446,000 (-50.51%)

$150,420,000 (-33.94%)

$227,686,000 (61.05%)

$141,375,000 (-38.15%)

Tangible Asset Value

$144,663,000 (-36.01%)

$226,060,000 (-32.39%)

$334,340,000 (62.21%)

$206,111,000 (-24.61%)

Market Capitalization

$176,652,060 (-36.85%)

$279,750,504 (-52.15%)

$584,674,802 (30.71%)

$447,291,601 (-75.46%)

Average Equity

$6,988,000 (-88.51%)

$60,798,250 (-46.77%)

$114,211,500 (-31.89%)

$167,685,250 (-18.01%)

Average Assets

$172,923,500 (-36.90%)

$274,039,750 (-5.49%)

$289,952,000 (25.34%)

$231,323,250 (-4.60%)

Invested Capital Average

$62,507,500 (-24.81%)

$83,138,250 (3.46%)

$80,357,250 (1120.08%)

$6,586,250 (-63.36%)

Shares

123,532,909 (2.45%)

120,582,114 (20.86%)

99,773,857 (38.74%)

71,911,833 (4.98%)